Skip to main content

About Thomas M. Keck

I am interested in developing new medications for neuropsychiatric disorders, including Alzheimer’s disease, schizophrenia, ADHD, pain, anxiety, and drug addiction. My lab works closely with medicinal chemists to design and test new drug-like molecules, using molecular and behavioral pharmacology methods to evaluate their preclinical potential. Current research targets include the dopamine D4 receptor, the mu opioid receptor, and the trace amine-associated receptor 1.

Positions

2014 - Present Assistant Professor, Chemistry & Biochemistry, Rowan University College of Science & Mathematics
to
2014 - Present Assistant Professor, Molecular & Cellular Biosciences, Rowan University College of Science & Mathematics
to
2014 - Present Joint appointment, Cooper Medical School of Rowan University
to
2009 - 2014 IRTA Postdoctoral Fellow, National Institute on Drug Abuse ‐ Molecular Targets and Medications Discovery Branch
to
2003 - 2004 Research Associate (Neurology), University of California Los Angeles David Geffen School of Medicine
to

Curriculum Vitae




Grants

2019 - Present Analgesia without Addiction: Synthesis and Development of Novel Analgesics
New Jersey Health Foundation - PC 44-19
Role: PI
Colleague(s): Gustavo Moura-Letts (Co-I)
2018 - Present ELUCIDATING THE IMPACT OF THE NPC1NMF164 MUTATION IN THE POSTNATAL CEREBELLAR DEVELOPMENT OF A MOUSE MODEL OF NIEMANN-PICK TYPE C DISEASE
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE - 1R15NS104994
Role: Co-investigator
Colleague(s): Ileana Soto-Reyes (PI), Ben Carone (Co-I)
2018 - Present Research Experiences for Undergraduates (REU) Site for Biomedical Materials, Devices, Therapeutics, and Emerging Frontiers
National Science Foundation - NSF EEC 1757815
Role: Faculty Mentor
Colleague(s): Mary Staehle (PI), Mark Byrne (PI); Faculty Mentors/Investigators: M Alpaugh, V Beachley, A Bottaro, N Bouaynaya, B Fischer, P Galie, M George-Weinstein, M Hickman, X Hu, L Perez, W Xue
2017 - Present ABUSE LIABILITY AND ANTI-ADDICTION POTENTIAL OF THE ATYPICAL MU OPIOID RECEPTOR AGONIST IBNTXA
NATIONAL INSTITUTE ON DRUG ABUSE, NIH - 1R03DA041560
Role: PI
Colleague(s): Bradford Fischer (Co-I)
$
to
Enter a valid date range.

Professional Service and Affiliations

2019 - Present Vice President (President-in-waiting), Mid-Atlantic Pharmacology Society
2016 - Present Member, Philadelphia Chapter of the Society for Neuroscience
2015 - Present Member, The American Society for Pharmacology and Experimental Therapeutics (ASPET)
2015 - 2018 Councilor, Mid-Atlantic Pharmacology Society
to
Enter a valid date range.

Honors and Awards

  • 2015 Frances R. Lax Faculty Development Award, Rowan University
  • 2013 Mentoring Award for Fellows, NIDA, NIH
  • 2013 Postdoctoral Mentor Award, NIH
  • 2012 & 2013 Fellows’ Award for Research Excellence, NIH
  • 2017 Maharaj Ticku Memorial Travel Fellowship for New Investigators Award, Behavior, Biology and Chemistry Conference

Courses

  • Seminar
  • Introduction to Biomedical Sciences
  • Medical Biochemistry
  • General Aspects of Pharmacology
  • Biochemistry

Education

to
2009 PhD, Oregon Health and Science University ‐ Physiology & Pharmacology
to
2003 BS, University of Southern California ‐ Biomedical-Biochemical Engineering
to



Recent Works (5)